94 results
Page 4 of 5
8-K
EX-1.1
hou vdwpnb3
27 Nov 19
X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class B Warrants
5:18pm
424B5
ee6e knqzb
27 Nov 19
Prospectus supplement for primary offering
12:00am
424B5
9nqk gupl8
25 Nov 19
Prospectus supplement for primary offering
4:19pm
8-K
EX-99.1
9hgrj18g5tw1a479wizy
7 Nov 19
X4 Pharmaceuticals Reports Third Quarter 2019 Financial Results and Recent Business Highlights
7:10am
8-K
EX-99.1
e5rzd67
26 Jun 19
Other Events
8:44am
8-K
EX-1.1
l0o qbvynls
15 Apr 19
X4 Pharmaceuticals Prices $85.8 Million Public Offering of Common Stock and Class A Warrants
4:41pm
424B5
trdfjnmizq75yxzdkm1
15 Apr 19
Prospectus supplement for primary offering
4:38pm
8-K
kgils04jb8m
12 Apr 19
X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class A Warrants
6:08am
424B5
0xhmjv wj
12 Apr 19
Prospectus supplement for primary offering
6:05am
8-K
EX-99.2
2xwrdzp7ax
11 Apr 19
Other Events
4:00pm
8-K
EX-99.1
1hijr9tp8dd3i9zmdv
11 Apr 19
Other Events
4:00pm
8-K/A
EX-99.1
8bw3nfb96cmq7
3 Apr 19
Index to Consolidated Financial Statements
12:00am
8-K/A
EX-99.2
w4ay7yta4s59ni1tzii
3 Apr 19
Index to Consolidated Financial Statements
12:00am
8-K
EX-10.11
fgmuxf
13 Mar 19
X4 Pharmaceuticals Completes Merger with Arsanis
5:28pm
8-K
EX-99.1
hz10f3 4c3xdfz
13 Mar 19
X4 Pharmaceuticals Completes Merger with Arsanis
5:28pm
8-K
EX-10.9
9bh p8h7h8r
13 Mar 19
X4 Pharmaceuticals Completes Merger with Arsanis
5:28pm